Skip to content

Treatment of Preterm labour

Nicorandil Versus Nifedipine in the treatment of Preterm Labour: A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201405000757313
Enrollment
200
Registered
2014-01-31
Start date
2014-02-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth preterm labour

Interventions

oral nicorandil

Sponsors

Menoufia faculty of medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All women who presented to the labor ward between 24 and 34 weeks of pregnancy (determined by the date of the last menstrual period when known or by early ultrasound) will be assessed for enrollment into the study.

Exclusion criteria

Exclusion criteria: -Cervix dilatation greater than 5 cm. -Polyhydramnios [amniotic fluid index (AFI) greater than 20 cm] and oligohydramnios (AFI less than 10 cm). -Fetal macrosomia (estimated fetal weight of 4 kg or more). - Suspected intrauterine infection (a temperature greater than 38°C). -Growth restriction. -Major antepartum hemorrhage. -Major maternal medical disorders. - Multiple pregnancy. -Hypertension in pregnancy and blood pressure less than 90/50 mm Hg. -Signs of fetal distress. -Lethal fetal anomaly. -Contraindication for the use of nifedipine and/or nicorandil.

Design outcomes

Primary

MeasureTime frame
Prolongation of pregnancy for a period of 48 hours

Secondary

MeasureTime frame
adverse effects of both drugs;Prolongation of pregnancy;Neonatal outcome

Countries

Egypt

Contacts

Public ContactRagab Dawood

lecturer at department of obstetrics and gynecology, menoufia faculty of medicine

Dr_ragabdawood@yahoo.com00201006426492

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026